Head and Neck Cancer Patients With Oral Mucositis Treated With Ketamine Oral Rinse

Participation Deadline: 11/01/2027
Apply Now

Description

Patients with histologically proven head and neck cancer undergoing radiation or concurrent chemoradiation as part of their treatment plan, will either receive ketamine oral rinse or unmedicated oral rinse to use 4 times a day if they develop oral mucositis during their radiation.

Patients will be monitored during treatment and up to 30 days after and will utilize a pain diary to document daily.